Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Apollo Hospital share...

    Apollo Hospital share price plummet after IHH Exits with Stake Sale at Rs 838 crores

    Written by savita thakur thakur Published On 2017-05-19T12:51:20+05:30  |  Updated On 19 May 2017 7:21 AM GMT
    Apollo Hospital share price plummet after IHH Exits with Stake Sale at Rs 838 crores

    Integrated (Mauritius) Healthcare Holdings Ltd.,(IHH) sold its remaining stake in Apollo Hospital Enterprise Ltd causing a turmoil in the share prices of the Indian healthcare giant .


    An arm of Malaysian sovereign fund Khazanah Nasional Bhd, IHH sold 68.4 lakh equity shares, i.e., 4.78 percent stake, at a price of Rs 1,246.10 per share, a discount of 2.7 percent to Wednesday’s closing price of Rs 1,281.60. The investment arm had appointed Deutsche Bank as the sole book runner for this stake sale, valued at Rs 838.5 crore.


    IHH had bought stake in Apollo Hospitals in 2011, first purchasing 1.1 crore shares in May and then an additional 40.9 lakh shares in October, the same year. The average cost of acquiring these shares was Rs 480. Almost six years later, the firm has got back more than 2.5 times its investment in the hospital chain.



    "They (IHH) are looking at India at a much bigger play now, and with a Rs 1,800 crore valuation at present, selling the 11 per cent share in AHEL could help them to subsidise their India play," said a source close to the development on condition of anonymity told
    BS

    IHH had earlier sold 6.07 percent stake in Apollo Hospitals for Rs 1,070 crore on March 2, 2017. The proceeds would be used to meet working capital needs, the company had said in a statement issued on the same day, after the deal was announced.


    IHH Healthcare Berhad, a healthcare group in which Malaysia government's sovereign wealth fund Khazanah Nasional holds a majority stake, is consolidating its India platform by rebranding Global Hospitals, in which it holds a majority stake, under the brand Gleneagles. The company has sold more than half of its stake in Apollo Hospitals, which analysts expect is an action towards strengthening its presence in India.

    Apollo Apollo Hospitals Global Hospitals IHH IHH Healthcare IHH Healthcare Berhad Khazanah Nasional Bhd Stake holding 
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      X